AERIE PHARMACEUTICALS INC | Business Contracts

First Supplemental Indenture, dated as of November 21, 2022, by and between Aerie Pharmaceuticals, Inc. and Wilmington Trust, National Association (Filed With SEC on November 21, 2022)

Agreement and Plan of Merger, dated as of August 22, 2022, by and among the Company, Parent and Merger Sub (Filed With SEC on August 23, 2022)

Renewal to the Manufacture and Supply Agreement, dated as of January 3, 2022, by and between Cayman Chemical Company, Incorporated and Aerie Distribution, Incorporated (Filed With SEC on May 6, 2022)

Employment Agreement, dated as of March 15, 2022, by and between Aerie Pharmaceuticals, Inc. and Peter Lang (Filed With SEC on May 6, 2022)

Aerie Pharmaceuticals, Inc. Nonqualified Deferred Compensation Plan and Adoption Agreement (Filed With SEC on May 6, 2022)

Form of Aerie Pharmaceuticals, Inc. Inducement Award Plan Restricted Stock Agreement (Filed With SEC on February 25, 2022)

Form of Aerie Pharmaceuticals, Inc. Inducement Award Plan Incentive Stock Option Agreement (Benjamin F. McGraw, III, Pharm.D.) (Filed With SEC on February 25, 2022)

Form of Aerie Pharmaceuticals, Inc. Inducement Award Plan Restricted Stock Agreement (Raj Kannan) (Filed With SEC on February 25, 2022)

Description of the Registrant's Securities (Filed With SEC on February 25, 2022)

Third Amendment to Contract Manufacturing Supply Agreement, dated as of January 1, 2020, by and between Bausch & Lomb Incorporated, Aerie Pharmaceuticals, Inc. and Aerie... (Filed With SEC on February 25, 2022)

Collaboration and License Agreement, dated as of December 6, 2021, by and between Aerie Pharmaceuticals Ireland, Ltd. and Santen SA (Filed With SEC on February 25, 2022)

Employment Agreement, dated as of December 15, 2021, by and between Aerie Pharmaceuticals, Inc. and Raj Kannan (Filed With SEC on February 25, 2022)

Form of Aerie Pharmaceuticals, Inc. Inducement Award Plan Nonqualified Stock Option Agreement (Raj Kannan) (Filed With SEC on February 25, 2022)

Letter Agreement, dated as of September 20, 2021, by and between Aerie Pharmaceuticals, Inc. and Benjamin F. McGraw, III, Pharm.D (Filed With SEC on November 5, 2021)

Description of the Registrant's Securities (Filed With SEC on February 26, 2021)

Collaboration and (Filed With SEC on February 26, 2021)

Amendment to Aerie Pharmaceuticals, Inc. Second Amended & Restated Inducement Award Plan (Filed With SEC on February 24, 2020)

Description of the Registrants Securities (Filed With SEC on February 24, 2020)

Employment Agreement, dated as of October 7, 2019, by and between Aerie Pharmaceuticals, Inc. and David Hollander (Filed With SEC on February 24, 2020)

Form of Aerie Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement (Filed With SEC on February 24, 2020)

Form of Additional Capped Call Transaction Confirmation (Filed With SEC on September 13, 2019)

Form of Capped Call Transaction Confirmation (Filed With SEC on September 10, 2019)

Indenture, dated as of September 9, 2019, by and between Aerie Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on September 10, 2019)

Amended and Restated Credit Agreement, dated as of May 2, 2019, by and among Aerie Pharmaceuticals, Inc., Aerie Distribution, Inc., the other Loan Parties (as defined therein)... (Filed With SEC on May 3, 2019)

Amended and Restated Guaranty and Security Agreement, dated as of May 2, 2019, by and among Aerie Pharmaceuticals, Inc., the other Grantors and Guarantors (each as defined... (Filed With SEC on May 3, 2019)

First Amendment to Contract Manufacturing Supply Agreement, dated as of May 31, 2018, by and between Bausch & Lomb Incorporated, Aerie Pharmaceuticals, Inc. and Aerie Distribution... (Filed With SEC on November 7, 2018)

Second Amendment to Contract Manufacturing Supply Agreement, dated as of August 15, 2018, by and between Bausch & Lomb Incorporated, Aerie Pharmaceuticals, Inc. and Aerie... (Filed With SEC on November 7, 2018)

Manufacture and Supply Agreement, dated as of January 1, 2018, by and between Cayman Chemical Company, Incorporated and Aerie Distribution, Incorporated (Filed With SEC on November 7, 2018)

Contract Manufacturing Supply Agreement, dated as of December 9, 2014, by and between Bausch & Lomb Incorporated and Aerie Pharmaceuticals, Inc (Filed With SEC on November 7, 2018)

First Amendment to Credit Agreement, dated as of August 7, 2018, by and among Aerie Pharmaceuticals, Inc., the guarantors party thereto, the lenders party thereto, and Deerfield... (Filed With SEC on August 9, 2018)

Guaranty and Security Agreement, dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., the other Grantors and Guarantors (each as defined therein) party thereto... (Filed With SEC on July 23, 2018)

Credit Agreement, dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., Aerie Distribution, Inc., the other Loan Parties (as defined therein) party thereto from... (Filed With SEC on July 23, 2018)

Registration Rights Agreement, dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., Deerfield Private Design Fund III, L.P., Deerfield Partners, L.P. and Deerfield... (Filed With SEC on July 23, 2018)

Exchange and Termination Agreement, dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., Deerfield Private Design Fund III, L.P., Deerfield Partners, L.P. and... (Filed With SEC on July 23, 2018)

Employment Agreement, dated January 19, 2018, by and between Aerie Pharmaceuticals, Inc. and John LaRocca (Filed With SEC on May 9, 2018)

Underwriting Agreement, dated January 23, 2018, by and between Aerie Pharmaceuticals, Inc. and Cantor Fitzgerald & Co., as representative of the several underwriters named in... (Filed With SEC on January 26, 2018)

Sales Agreement, dated December 19, 2017, by and between Aerie Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 19, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on July 26, 2017)

AERIE PHARMACEUTICALS, INC. 1,395,349 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 1, 2017)

AERIE PHARMACEUTICALS, INC. Up to $50,000,000 of Shares ofCommon Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on May 25, 2017)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 9, 2017)

AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 9, 2017)

FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT (Filed With SEC on March 9, 2017)

AERIE PHARMACEUTICALS, INC. INDUCEMENT AWARD PLAN (Effective as of December 7, 2016) (Filed With SEC on March 9, 2017)

AERIE PHARMACEUTICALS, INC. INDUCEMENT AWARD PLAN FORM OF NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on March 9, 2017)

AERIE PHARMACEUTICALS, INC. INDUCEMENT AWARD PLAN RESTRICTED STOCK AGREEMENT (Filed With SEC on March 9, 2017)

AERIE PHARMACEUTICALS, INC. 2,542,373 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 21, 2016)

AERIE PHARMACEUTICALS, INC. Up to $50,000,000 of Shares ofCommon Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on September 15, 2016)

AERIE PHARMACEUTICALS, INC. Up to $50,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 6, 2015)

SEPARATION AND RELEASE AGREEMENT (Filed With SEC on July 9, 2015)

FORM OF INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on February 24, 2015)

AERIE PHARMACEUTICALS, INC. 2013 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK AGREEMENT (Filed With SEC on February 24, 2015)

FORM OF INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on February 24, 2015)

SECURITY AGREEMENT among AERIEPHARMACEUTICALS, INC. and DEERFIELD PARTNERS, L.P., DEERFIELD INTERNATIONAL MASTER FUND, L.P., DEERFIELD PRIVATE DESIGN FUND III, L.P., DEERFIELD... (Filed With SEC on November 12, 2014)

PORTIONS OF THIS EXHIBIT DENOTED WITH THREE ASTERISKS (***) HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. NOTE PURCHASE AGREEMENT (Filed With SEC on November 12, 2014)

FORM OF INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 19, 2014)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 20, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on December 20, 2013)

INDEMNIFICATION AGREEMENT (Filed With SEC on October 21, 2013)

Shares Aerie Pharmaceuticals, Inc. Common Stock ($0.001 Par Value) FORM OF EQUITYUNDERWRITING AGREEMENT (Filed With SEC on October 15, 2013)

SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on October 3, 2013)

AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 3, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on October 3, 2013)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on October 3, 2013)

AERIE PHARMACEUTICALS, INC. 106 Glenhaven Drive Chapel Hill,North Carolina 27516 July 29, 2005 (Filed With SEC on October 3, 2013)

AERIE PHARMACEUTICALS, INC. 135 US Highway 206, Suite 9 Bedminster, NJ 07921 December 15, 2011 (Filed With SEC on October 3, 2013)

AERIE PHARMACEUTICALS, INC. 135 US Highway 206, Suite 15 Bedminster, NJ 07921 September 24, 2012 (Filed With SEC on October 3, 2013)

CONSULTING AGREEMENT (Filed With SEC on October 3, 2013)

FIRST AMENDMENT TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 3, 2013)

FIFTH AMENDMENT OF THE AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)

FOURTH AMENDMENT OF THE AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)

THIRD AMENDMENT OF THE AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)

SECOND AMENDMENT OF THE AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)

FIRST AMENDMENT OF AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)

AERIE PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on October 3, 2013)

FORM OF AERIEPHARMACEUTICALS, INC. OMNIBUS INCENTIVE PLAN (Adopted as of ) (Filed With SEC on October 3, 2013)

FORM OF AERIEPHARMACEUTICALS, INC. EMPLOYEE STOCK PURCHASE PLAN ARTICLE I INTRODUCTION (Filed With SEC on October 3, 2013)

AERIE PHARMACEUTICALS INC (82)